4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-044079
Director sold 4,731 shares at an average $24.58 ($116,281)
- Director acquired 4,096 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Welgus Howard G. · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +822 | $6.52 | $5,361 | 39,200 | D |
| 2026-06-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +1,019 | $7.51 | $7,653 | 40,219 | D |
| 2026-06-15 | Exercise or conversion : show line 3 in the form 10b5-1 | +2,255 | $8.63 | $19,461 | 42,474 | D |
| 2026-06-15 | Sale : show line 4 in the form 10b5-1 | −4,096 | $24.41 | $99,980 | 38,378 | D |
| 2026-06-17 | Sale : show line 5 in the form 10b5-1 | −635 | $25.67 | $16,300 | 37,743 | D |
| Open-market sales · 4,731 sh · avg $24.58 · $116,281 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −822 | 9,040 | D |
| 2026-06-15 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −1,019 | 11,201 | D |
| 2026-06-15 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) | −2,255 | 24,797 | D |
Loading xslF345X06/wk-form4_1781743212.xml…